Showing results (1031-1040 of 4,634) with videos related to
Sort By:
Pageof 464
Anti-Cancer Drugs|August 10, 2022
Successful treatment with lenvatinib in a patient with thymic carcinoma presenting with cardiac tamponade: a case report and review of literatureKoki Nakashima, Takayuki Azuma, Rina Ohta, et al.Anti-Cancer Drugs|August 10, 2022
Circular RNA circVPRBP serves as a microRNA-106b-5p sponge to regulate proliferation and metastasis of cervical cancer cells via tripartite motif-containing protein 3Yingying Jiang, Wei Xu, Junzhen TaoAnti-Cancer Drugs|August 10, 2022
Association of genetic polymorphisms of CYP3A4 and CYP2D6 with gefitinib-induced toxicitiesWang Chun Kwok, David Chi Leung Lam, Mary Sau Man Ip, et al.Anti-Cancer Drugs|August 10, 2022
Identification of exosomal circRNA CD226 as a potent driver of nonsmall cell lung cancer through miR-1224-3p/high mobility group AT-hook 2 axisLihong Peng, Yunpeng Cao, Chao HuAnti-Cancer Drugs|August 10, 2022
Savolitinib monotherapy exerted significant benefit in a non-small cell lung cancer patient with osimertinib resistance harboring primary EGFR L858R mutation and MET amplification: a case reportPei Ma, Ruohan Huang, Yunru Gu, et al.Anti-Cancer Drugs|August 30, 2021
Successful treatment of two patients with unresectable lung squamous cell carcinoma with tislelizumab regardless of programmed death-ligand 1 expression: a report of two casesQiaoyuan Wu, Yunliang Cao, Yi Li, et al.Anti-Cancer Drugs|August 30, 2021
Paeoniflorin inhibits proliferation and migration of psoriatic keratinocytes via the lncRNA NEAT1/miR-3194-5p/Galectin-7 axisDan Wang, Shiping Cheng, Guoming Zou, et al.Anti-Cancer Drugs|August 30, 2021
Circular noncoding RNA circ_0007334 sequestrates miR-577 to derepress KLF12 and accelerate colorectal cancer progressionLiang Bai, Zhifeng Gao, An Jiang, et al.Anti-Cancer Drugs|August 30, 2021
Fifty-five months progression-free survival with crizotinib treatment in coexistence of ALK and ROS1 rearrangements in lung adenocarcinoma: an extremely rare case and review of the literatureMustafa Korkmaz, Melek Karakurt EryilmazAnti-Cancer Drugs|September 20, 2021
Warburg and pasteur phenotypes modulate cancer behavior and therapyCaner Karaca, Atilla Tokatli, Anja Tokatli, et al.Pageof 464